Acaster Lloyd Consulting Ltd Acaster Lloyd Consulting Ltd
  • Home
  • About us
  • Our team
  • Services
  • Publications
  • Careers
  • Contact us

Using the EQ-5D to measure caregiver health-related quality of life in rare pediatric disease: a study in aromatic L-amino acid decarboxylase deficiency

Acaster, S., Williams, K., Skrobanski, H., Buesch, K. (2022). Using the EQ-5D to measure caregiver health-related quality of life in rare pediatric disease: a study in aromatic L-amino acid decarboxylase deficiency. Future Neurology, 17, 2.

Read More
Symptoms and impacts of aromatic L-amino acid decarboxylase (AADC) deficiency among individuals with different levels of motor function

Williams K., Skrobanski, H., Buesch, K., Acaster, S. (2022). Symptoms and impacts of aromatic l-amino acid decarboxylase (AADC) deficiency among individuals with different levels of motor function. Orphanet J Rare Dis, 17: 128.

Read More
Exploring Health-Related Quality of Life Burden in Peanut Allergy and the Potential Benefit of Oral Immunotherapy: Estimation of Health State Utility Values for Children and Adolescents and Their Caregivers

Gallop, K. Acaster, S., de Vries, J., Browne, R., Ryan, R., Bker, S., Du Toit, G. (2022). Exploring Health-Related Quality of Life Burden in Peanut Allergy and the Potential Benefit of Oral Immunotherapy: Estimation of Health State Utility Values for Children and Adolescents and Their Caregivers. Patient Preference and Adherence, 16, 1269-1278.

Read More
Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United Kingdom

Lo, SH., Gorni, K., Sutherland, CS., Marti, Y., Lloyd, AJ., Paracha, N. (2022). Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United Kingdom. Pharmacoeconomics, 40, 91-102.

Read More
Patient and Caregiver Treatment Preferences in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy: A Discrete Choice Experiment Survey in Five European Countries

Lo, SH., Lawrence, C., Gorni, K., Sutherland, CS., Marti, Y., Lloyd, AJ., Paracha, N. (2022). Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United Kingdom. Pharmacoeconomics, 40, 91-102.

Read More
Time Trade-Off Utilities for Hereditary Angioedema Health and Caregiver States

Lo, SH., Lloyd, AJ., Elkhalifa, S., Sisic, Z., van Nooten, FE. (2022). Time Trade-Off Utilities for Hereditary Angioedema Health and Caregiver States. Pharmacoeconomics Open, 6, 231-239.

Read More
Patient and Caregiver Health State Utilities in Tuberous Sclerosis Complex

Lo, SH., Marshall, J., Skrobanski, H., Lloyd, A. (2022). Patient and Caregiver Health State Utilities in Tuberous Sclerosis Complex. Pharmacoeconomics Open, 6, 105-121.

Read More
Symptoms and impacts of ambulatory nonsense mutation Duchenne muscular dystrophy: a qualitative study and the development of a patient-centred conceptual model

Williams K., Davidson, I., Rance, M., Boehnke, A., Buesch, K., Acaster, S. (2021). Symptoms and impacts of ambulatory nonsense mutation Duchenne muscular dystrophy: a qualitative study and the development of a patient-centred conceptual model. Journal of Patient-Reported Outcomes.

Read More
The EQ-5D and the EuroQol Group

Lloyd AJ & Pickard SA. (2019). Value in Health, 22(1), 21-22.

Read More
Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report

Brazier J, Ara R, Azzabi I ... Lloyd AJ, Paisley MA & Pickard SA. (2019). Value in Health, 22(3), 267-275.

Read More
Patient reported outcome and observer reported outcome assessment in rare disease trials

Acaster, S. (2017) Value in Health, 20(7)

Read More
A novel patient-derived conceptual model of the impact of coeliac disease in adults: Implications for patient-reported outcome and health-related quality of life instrument development

Leffler D, Acaster S, Gallop K, Dennis M, Adelman D. (2017) Value in Health

Read More
Social preference weights for treatments in Fabry disease in the UK: a discrete choice experiment

Lloyd AJ, Gallop K, Ali S, Hughes D & MacCulloch A. (2017) Current medical research and opinion, 33(1), 23-29

Read More
Special Edition on Utility Measurement

Lloyd, AJ PharmacoEconomics (2017). 35(Suppl 1): 5

Read More
EQ-5D: Moving from Three Levels to Five

Lloyd AJ Value Health 2018 21, 57–58

Read More
Acaster Lloyd Consulting Ltd logo
Menu
  • Home
  • About us
  • Our team
  • Services
  • Publications
  • Careers
  • Contact us
Contact

Acaster Lloyd
8th Floor
Lacon House
84 Theobalds Road
London
WC1X 8NL

Tel: +44 (0)20 3978 1680

© 2019-2023

Website by Tinker Tailor Design

  • Privacy Policy
  • Cookie Policy
  • Home
  • About us
  • Our team
  • Services
  • Publications
  • Careers
  • Contact us
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Settings" to provide a controlled consent.
Settings Accept All
Cookies

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gat_gtag_UA_160288895_11 minuteSet by Google to distinguish users.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
Save & Accept
Powered by CookieYes Logo